Menu
Recruiting NCT01585675

Specimen Banking From Patients With Lung Cancer

Observational Lung Neoplasms

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Lung Neoplasms. Basic parameters: 18 years — 85 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The primary objective of the protocol is to develop a comprehensive specimen banking program from patients with lung cancer for future translation research, which will enable the investigators to detect lung cancer earlier, develop better therapies and explore screening and prevention strategies.

Detailed description

The aims of the study are as follows: 1) to continue to unravel the complex biology of lung cancer 2) to identify early detection and prognostic markers to guide therapeutic decision 3) to define markers of response and/or resistance to drug therapy, and 4) to identify new therapeutic and prevention targets.

Primary outcome measures

  • Development of a comprehensive specimen banking program from patients with lung cancer for future translational research. [Time frame: 6 years]

Eligibility criteria

Inclusion criteria

  • Subjects who are undergoing further testing for the diagnosis or treatment of lung cancer.
  • Oral and written informed consent

Exclusion criteria

1\. Any individual who does not give oral and written consent for participation

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Other

Study locations

United States · 1 center
  • University of Colorado Cancer Center — Aurora

Identifiers

NCT: NCT01585675 · 04-0688.cc · P50CA058187

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗